Aemetis Inc (NASDAQ:AMTX) does about 1.22M shares in volume on a normal day but saw 1198230 shares change hands in Monday’s trading. The company now has a market cap of 217.70M USD. Its current market price is $5.51, marking a decrease of -8.01% compared to the previous close of $5.99. The 52 week high reached by this stock is $8.99 whilst the lowest price level in 52 weeks is $1.16.
Aemetis Inc (AMTX) has a 20-day trading average at $4.08 and the current price is -38.71% off the 52-week high compared with 375.00% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.75 and its 200-day simple moving average is $4.99. If we look at the stock’s price movements over the week, volatility stands at 14.98%, which decreases to 13.06% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 67.90 to suggest the stock is neutral.
The consensus objective for the share price is $11.50, suggesting that the stock has a potential upside of 52.09% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 16, 2023 when UBS upgraded the stock to “Buy” and issued a price target of between $2.50 and $10.50. UBS initiated its price target at $4.25.
Aemetis Inc (AMTX) stock is down -1.08% over the week and 51.79% over the past month. Its price is 5.15% year-to-date and 144.89% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/30/2023, with the company’s earnings per share (EPS) of -$0.64 below consensus estimates by -$0.3. AMTX’s earnings per share are forecast to shrink by -17.20% this year and 90.20% over next year. Expected sales for next quarter are $89.29 million, which analysts say will come at $380.2 million for the current fiscal year and next year at $541.64 million. In addition, estimates put the company’s current quarterly revenue at an average of $77.79 million.
To reach the target analysts have set, the stock logically needs to grow 52.09 percent from here.
Outstanding shares total 40.97M with insiders holding 10.94% of the shares and institutional holders owning 27.06% of the company’s common stock. The company has a return on investment of -29.31%. The beta has a value of 1.01. Price to sales ratio is 1.17.
